Top 10 OTC Pharmaceutical Companies by Consumer Sales in Japan

Robert Gultig

21 November 2025

Top 10 OTC Pharmaceutical Companies by Consumer Sales in Japan

User avatar placeholder
Written by Robert Gultig

21 November 2025

Introduction:

The pharmaceutical industry in Japan continues to be one of the largest and most profitable markets in the world. With a growing aging population and increasing healthcare expenditures, the demand for over-the-counter (OTC) pharmaceutical products remains strong. According to recent data, the OTC pharmaceutical market in Japan is estimated to be worth over $10 billion, with steady growth projected in the coming years.

Top 10 OTC Pharmaceutical Companies by Consumer Sales in Japan:

1. Taisho Pharmaceutical Co., Ltd.
Taisho Pharmaceutical Co., Ltd. is the leading OTC pharmaceutical company in Japan, with a market share of over 20%. Known for their popular brands such as Lipovitan and Pabron, Taisho Pharmaceutical has consistently delivered high-quality products to meet the diverse needs of consumers.

2. Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited holds the second spot in the list of top OTC pharmaceutical companies in Japan. With a market share of around 15%, Takeda is a key player in the industry, offering a wide range of OTC products for various health conditions.

3. Otsuka Pharmaceutical Co., Ltd.
Otsuka Pharmaceutical Co., Ltd. is another major player in the Japanese OTC pharmaceutical market, with a market share of approximately 10%. The company is known for its innovative products and strong commitment to improving the health and well-being of consumers.

4. Eisai Co., Ltd.
Eisai Co., Ltd. is a well-established pharmaceutical company in Japan, with a market share of around 8% in the OTC segment. The company’s focus on research and development has led to the introduction of several successful OTC products in the market.

5. Mochida Pharmaceutical Co., Ltd.
Mochida Pharmaceutical Co., Ltd. is a prominent player in the Japanese OTC pharmaceutical industry, with a market share of approximately 6%. The company’s diverse product portfolio caters to a wide range of consumer healthcare needs.

6. Sato Pharmaceutical Co., Ltd.
Sato Pharmaceutical Co., Ltd. is a leading OTC pharmaceutical company in Japan, with a market share of around 5%. The company’s strong presence in the market is attributed to its high-quality products and consumer-friendly pricing.

7. Hisamitsu Pharmaceutical Co., Inc.
Hisamitsu Pharmaceutical Co., Inc. is a key player in the Japanese OTC pharmaceutical market, with a market share of approximately 4%. The company’s focus on pain relief products has helped it establish a strong presence in the industry.

8. SS Pharmaceuticals Co., Ltd.
SS Pharmaceuticals Co., Ltd. is a growing player in the Japanese OTC pharmaceutical market, with a market share of around 3%. The company’s commitment to providing affordable and effective healthcare solutions has resonated well with consumers.

9. Kobayashi Pharmaceutical Co., Ltd.
Kobayashi Pharmaceutical Co., Ltd. is a well-known OTC pharmaceutical company in Japan, with a market share of approximately 2%. The company’s wide range of products, including skincare, digestive health, and cold remedies, caters to diverse consumer needs.

10. Nippon Chemiphar Co., Ltd.
Nippon Chemiphar Co., Ltd. rounds out the list of top OTC pharmaceutical companies in Japan, with a market share of around 1%. The company’s strong focus on research and development has led to the introduction of innovative OTC products in the market.

Insights:

The OTC pharmaceutical market in Japan is expected to continue its steady growth trajectory in the coming years, driven by factors such as the aging population, increasing healthcare awareness, and expanding product offerings. With the rise of e-commerce and digital marketing, companies are also exploring new ways to reach and engage with consumers. As the market becomes more competitive, companies will need to focus on innovation, product differentiation, and strategic partnerships to maintain their positions and drive growth. Overall, the future looks promising for the OTC pharmaceutical industry in Japan, with ample opportunities for companies to thrive and succeed.

Related Analysis: View Previous Industry Report

Author: Robert Gultig in conjunction with ESS Research Team

Robert Gultig is a veteran Managing Director and International Trade Consultant with over 20 years of experience in global trading and market research. Robert leverages his deep industry knowledge and strategic marketing background (BBA) to provide authoritative market insights in conjunction with the ESS Research Team. If you would like to contribute articles or insights, please join our team by emailing support@essfeed.com.
View Robert’s LinkedIn Profile →